Visual neurophisiology
2023 Activity indicators
- 4 competitive national public projects: ISCIII, MINECO/MICIIN
- 1 competitive HR contract: FPU
- 6 publications
- IF: 41.61
- Q1 publications: 4 (67%)
- D1 publications: 3 (50%)
- National public agency project evaluators: 2 PI
- Members of Editorial Committees: 1 PI
- 2 actions with an impact on society: talks
Milestones
- Development of a new animal model for therapeutic testing of antioxidant and neuroprotective agents (Espitia-Arias MD, de la Villa P, Paleo-García V, Germain F, Milla-Navarro S. Oxidative Model of Retinal Neurodegeneration Induced by Sodium Iodate: Morphofunctional Assessment of the Visual Pathway. Antioxidants (Basel). 2023 Aug 10;12(8):1594. DOI: 10.3390/antiox12081594. PMID: 37627589)
- Demonstration of the functional origin of electroretinogram oscillatory potentials (Liao F, Liu H, Milla-Navarro S, Villa P, Germain F. Origin of Retinal Oscillatory Potentials in the Mouse, a Tool to Specifically Locate Retinal Damage. Int J Mol Sci. 2023 Feb 4;24(4):3126. DOI: 10.3390/ijms24043126. PMID: 36834538)
- Demonstration of the importance of calcium sensors in the regulation of neuronal survival processes (Muñoz-Reyes D, McClelland LJ, Arroyo-Urea S, Sánchez-Yepes S, Sabín J, Pérez-Suárez S, Menendez M, Mansilla A, García-Nafría J, Sprang S, Sanchez-Barrena MJ. The neuronal calcium sensor NCS-1 regulates the phosphorylation state and activity of the Gα chaperone and GEF Ric-8A. Elife. 2023 Nov 29:12:e86151. DOI: 10.7554/eLife.86151. PMID: 38018500)
- Description of new elements required for the formation of highly specialized synapses (Jimeno D, Lillo C, de la Villa P, Calzada N, Santos E, Fernández-Medarde A. GRF2 Is Crucial for Cone Photoreceptor Viability and Ribbon Synapse Formation in the Mouse Retina. Cells. 2023 Nov 4;12(21):2574. DOI: 10.3390/cells12212574. PMID: 37947653)
- Consolidation of the group with the incorporation of members with expertise in basic biochemistry and pharmacology techniques.
Bibliometrics
ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
---|---|---|---|---|---|---|---|
2019 | 2 | 8.70 | 4.35 | 2 | 100 | 0 | 0 |
2020 | 11 | 60.90 | 6.09 | 9 | 82 | 3 | 27 |
2021 | 8 | 50.32 | 6.29 | 8 | 100 | 1 | 15 |
2022 | 7 | 61.88 | 8.84 | 7 | 100 | 1 | 14 |
2023 | 6 | 41.61 | 6.94 | 6 | 100 | 3 | 50 |
34 | 223.41 | 6.50 | 32 | 92 | 8 | 24 | |
* Only original articles, editorial material, guidelines and reviews.